Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models

SAN DIEGO, May 26 (Korea Bizwire) — Crown Bioscience today announced the expansion of their unique organoid platform with the addition of 130 Hubrecht Organoid Technology (HUB) patient-derived organoids (PDO). This marks a significant milestone in the development of CrownBio’s innovative organoid platform and the first, large-scale commercial availability of HUB PDO for oncology drug [...]